DIAGNOS-Announces-Financial-Contribution-of-400-000-from-the-Government-of-Canada
DIAGNOS-Announces-Financial-Contribution-of-400-000-from-the-Government-of-Canada
DIAGNOS-Announces-Engagement-of-Promoter
DIAGNOS-Announces-Engagement-of-Promoter
DIAGNOS-is-filing-for-the-Saudi-FDA-Authorization-of-Its-CARA-SYSTEM
DIAGNOS-is-filing-for-the-Saudi-FDA-Authorization-of-Its-CARA-SYSTEM
DIAGNOS-Announces-Amendment-to-Convertible-Debentures-1
DIAGNOS-Announces-Amendment-to-Convertible-Debentures-1
DIAGNOS-Opens-First-US-Office-in-Florida
DIAGNOS-Opens-First-US-Office-in-Florida
DIAGNOS-Announces-Amendment-to-Convertible-Debentures
DIAGNOS-Announces-Amendment-to-Convertible-Debentures
DIAGNOS-ouvre-son-premier-bureau-americain-en-Floride
DIAGNOS-ouvre-son-premier-bureau-americain-en-Floride
DIAGNOS-annonce-lengagement-dun-promoteur
DIAGNOS-annonce-lengagement-dun-promoteur
DIAGNOS-to-Extend-Exercise-Period-of-Stock-Warrants-Expiring-on-November-9-2025
DIAGNOS-to-Extend-Exercise-Period-of-Stock-Warrants-Expiring-on-November-9-2025
Validated-for-Global-Scale_-DIAGNOS-Passes-Annual-MDSAP-Audit-Solidifying-the-Pathway-to-Approvals-with-Health-Canada-FDA
Validated-for-Global-Scale_-DIAGNOS-Passes-Annual-MDSAP-Audit-Solidifying-the-Pathway-to-Approvals-with-Health-Canada-FDA
